TRAIL antibody
Quick Overview for TRAIL antibody (ABIN116275)
Target
See all TRAIL (TNFSF10) AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Specificity
- This antibody reacts with Human TRAIL/APO2 Ligand.
-
Purification
- Affinity chromatography.
-
Immunogen
- Highly pure (>98%) recombinant hTRAIL/Apo2L (humanTRAIL/Apo2L).
-
-
-
-
Application Notes
-
Neutralization: To yield one-half maximal inhibition [ND50] of the biological activity ofhTRAIL/Apo2L (30 ng/mL), a concentration of 0.5-0.8 μg/mL of this antibody is required. ELISA: To detect hTRAIL/Apo2L by direct ELISA (using 100 l/well antibody solution) aconcentration of at least 0.5 μg/mL of this antibody is required. This antigen affinitypurified antibody, in conjunction with compatible secondary reagents, allows the detectionof 0.2 - 0.4 ng/well of recombinant hTRAIL/Apo2L. Western Blot: To detect hTRAIL/Apo2L by Western Blot analysis this antibody can be usedat a concentration of 0.1 - 0.2 μg/mL. Used in conjunction with compatible secondaryreagents the detection limit for recombinant hTRAIL/Apo2L is 1.5 - 3.0 ng/lane, under eitherreducing or non-reducing conditions.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user. -
Restrictions
- For Research Use only
-
-
-
Reconstitution
- Restore in sterile water to a concentration of 0.1-1.0 mg/mL.
-
Buffer
- PBS, pH 7.2 without preservatives.
-
Preservative
- Without preservative
-
Handling Advice
- Avoid repeated freezing and thawing. Centrifuge vial prior to opening!
-
Storage
- 4 °C/-20 °C
-
Storage Comment
- Store the antibody prior to reconstitution at -20 °C. Following reconstitution the antibody can be stored at 2-8 °C for one month or at -20 °C for longer.
-
-
- TRAIL (TNFSF10) (Tumor Necrosis Factor (Ligand) Superfamily, Member 10 (TNFSF10))
-
Alternative Name
- CD253 / TRAIL
-
Background
- Apoptosis or programmed cell death is induced in cells by a group of death domain containing receptors. Binding of ligand to these receptors sends signals that activate members of the caspase family of proteases. The signals ultimately cause degradation of chromosomal DNA by activating DNase. TRAIL (TNF related apoptosis induced ligand) or Apo 2L initiates apoptosis of tumor cells by binding to either of its receptors, DR4 or DR5. These receptors consist of an extracellular TRAIL binding domain and a cytoplasmic "death domain". In addition, two decoy receptors for TRAIL have also been identified. These receptors, designated DcR1 and DcR2, lack the death domain. Binding of TRAIL to either of these receptors, therefore, does not transmit the death signal. Thus, these receptors represent a novel way of regulating cell sensitivity to a pro-apoptotic cytokine at the cell surface. TRAIL is expressed predominantly in spleen, lung, and prostate but also in many other tissues.Synonyms: APO2L, Apo-2 ligand, Apo-2L, TNF-related apoptosis-inducing ligand, TNFSF10, Tumor necrosis factor ligand superfamily member 10
-
Gene ID
- 8743
-
NCBI Accession
- NP_003801
-
UniProt
- P50591
-
Pathways
- Apoptosis, Positive Regulation of Endopeptidase Activity
Target
-